Cargando…
A Cryptic Site of Vulnerability on the Receptor Binding Domain of the SARS-CoV-2 Spike Glycoprotein
SARS-CoV-2 is a zoonotic virus that has caused a pandemic of severe respiratory disease—COVID-19—within several months of its initial identification. Comparable to the first SARS-CoV, this novel coronavirus’s surface Spike (S) glycoprotein mediates cell entry via the human ACE-2 receptor, and, thus,...
Autores principales: | Joyce, M. Gordon, Sankhala, Rajeshwer S., Chen, Wei-Hung, Choe, Misook, Bai, Hongjun, Hajduczki, Agnes, Yan, Lianying, Sterling, Spencer L., Peterson, Caroline E., Green, Ethan C., Smith, Clayton, de Val, Natalia, Amare, Mihret, Scott, Paul, Laing, Eric D., Broder, Christopher C., Rolland, Morgane, Michael, Nelson L., Modjarrad, Kayvon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217142/ https://www.ncbi.nlm.nih.gov/pubmed/32511298 http://dx.doi.org/10.1101/2020.03.15.992883 |
Ejemplares similares
-
564. SARS-CoV-2 Ferritin Nanoparticle Vaccines Elicit Broad SARS Coronavirus Immunogenicity
por: Joyce, M G, et al.
Publicado: (2021) -
Targeting the Spike Receptor Binding Domain Class V Cryptic Epitope by an Antibody with Pan-Sarbecovirus Activity
por: Jensen, Jaime L., et al.
Publicado: (2023) -
Multiple co-circulating HIV-1 subtypes in the Middle East and North Africa
por: Rolland, Morgane, et al.
Publicado: (2015) -
A SARS-CoV-2 vaccine candidate would likely match all currently circulating variants
por: Dearlove, Bethany, et al.
Publicado: (2020) -
Shark nanobodies with potent SARS-CoV-2 neutralizing activity and broad sarbecovirus reactivity
por: Chen, Wei-Hung, et al.
Publicado: (2023)